Morgan Stanley analyst Fernando Amaral downgraded Edenor (EDN) to Equal Weight from Overweight with a price target of $36, down from $52. The firm cites the stock’s uncompelling valuation, lingering regulatory headwinds, and distant company-specific catalysts amid “worse-than-expected regulation”, the analyst tells investors in a research note. Argentina macroeconomic changes remain fluid, but the firm prefers to wait for “higher visibility” from the sidelines, Morgan Stanley added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EDN:
- Edenor Reports Strong Financial Performance and Continued Investments in H1 2025
- Edenor SA Approves Interim Financial Statements for June 2025
- Edenor Reports Strong Financial Results for Mid-2025
- Edenor SA Reports Strong Revenue Growth in Mid-2025 Financials
- Edenor SA Files SEC Report to Reinforce Regulatory Compliance